Abstract: A One Health perspective on the use of genotypic methods for antimicrobial resistance prediction

April 5, 2024 — 

Abstract: A One Health perspective on the use of genotypic methods for antimicrobial resistance prediction

Antimicrobial resistance is a global One Health concern with critical implications for the health of humans, animals, and the environment. Phenotypic methods of bacterial culture and antimicrobial susceptibility testing remain the gold standards for the detection of antimicrobial resistance and appropriate patient care; however, genotypic-based methods, such as PCR, whole genome sequencing, and metagenomic sequencing, for detection of genes conferring antimicrobial resistance are increasingly available without inclusion of appropriate standards for quality or interpretation. Misleading test results may lead to inappropriate antimicrobial treatment and, in turn, poor patient outcomes and the potential for increased incidence of antimicrobial resistance. This article explores the current landscape of clinical and methodological aspects of antimicrobial susceptibility testing and genotypic antimicrobial resistance test methods. Additionally, it describes the limitations associated with employing genotypic-based test methods in the management of veterinary patients from a One Health perspective. The companion Currents in One Health by Maddock et al, AJVR, March 2024, addresses current and future needs for veterinary antimicrobial resistance research.

Maddock KJ, Burbick CR, Cole SD, et al. A One Health perspective on the use of genotypic methods for antimicrobial resistance prediction. J Am Vet Med Assoc. 2024;262(3):303-312. Published 2024 Jan 31. https://doi.org/10.2460/javma.23.12.0687